Pharmaceutical Executive
Marketers will need to address not only the benefits of the therapy but also the benefits of a diagnostic assay.
Kathleen Dunn, KFDunn Life Sciences
Advertisement
Articles by Kathleen Dunn, KFDunn Life Sciences
Advertisement
Latest Updated Articles
Personalized Medicines: Implications for PharmaDecember 1st 2009
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
2
FDA Approves Wegovy HD Injectable Under Accelerated Approval
3
What Are the ‘Last Mile Issues’ Impacting Pharma?
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5